Dimachkie , Mazen M., Michael Hanna, Pedro Machado, Laura Herbelin, Mamatha Pasnoor, Omar Jawdat, April McVey, et al. “Phase II Study of Arimoclomol in IBM FDA-OOPD ”. RRNMF Neuromuscular Journal 2, no. 3 (August 3, 2021): 104–142. Accessed November 24, 2024. https://journals.ku.edu/rrnmf/article/view/15728.